OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
489500$31950.0057

LK Chem Co Ltd

Specialty ChemicalsVerified

LK Chem Co Ltd maintains a strong liquidity position, with cash and equivalents amounting to KRW 16,221,818,560, representing 24.5% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, supported by a current ratio of 11.94, indicating a high ability to meet short-term obligations. The debt-to-equity ratio of 0.06 suggests a conservative capital structure with minimal leverage. In terms of profitability, LK Chem Co Ltd reported a net income of KRW 4,353,034,930 and an operating income of KRW 4,550,286,560. The return on equity (ROE) of 7.31% and return on assets (ROA) of 6.58% are in line with industry norms for specialty chemicals, though not significantly outperforming the median. The company's gross margin of 50.1% (calculated from gross profit and revenue) is strong, indicating efficient cost management. LK Chem Co Ltd operates in a single business segment focused on chemical materials for thin film deposition. The company's geographic exposure is concentrated in South Korea, with no disclosed international revenue segments. This concentration may pose risks in the event of regional economic or regulatory changes. The company's revenue growth trajectory is not explicitly provided, but the current price-to-earnings (P/E) ratio of 46.08 and price-to-book (P/B) ratio of 3.37 suggest a premium valuation relative to book value and earnings. The EV/EBITDA of 41.32 and EV/Revenue of 9.32 indicate that the market is pricing in future growth expectations. LK Chem Co Ltd's risk assessment indicates low liquidity and dilution risks. The company has no immediate filing-based liquidity or dilution flags, and the dilution potential is low, with no significant changes in shares outstanding between basic and diluted shares. The company's capital expenditure of KRW -9,995,289,110 (negative due to presentation) suggests a high level of investment in maintaining and expanding production capabilities. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's free cash flow of KRW -3,832,535,040 suggests that capital expenditures are currently outpacing operating cash flow, which may require continued reliance on cash reserves or financing.

30-day price · 489500-800.00 (-2.5%)
Low$29300.00High$38250.00Close$31200.00As of18 May, 00:00 UTC
Profile
CompanyLK Chem Co Ltd
Ticker489500.KQ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. LK Chem Co Ltd is a Korea-based company engaged in the development, manufacturing, and sales of chemical materials used in thin film deposition processes, primarily for the semiconductor industry.

Classification. LK Chem Co Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

LK Chem Co Ltd maintains a strong liquidity position, with cash and equivalents amounting to KRW 16,221,818,560, representing 24.5% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, supported by a current ratio of 11.94, indicating a high ability to meet short-term obligations. The debt-to-equity ratio of 0.06 suggests a conservative capital structure with minimal leverage. In terms of profitability, LK Chem Co Ltd reported a net income of KRW 4,353,034,930 and an operating income of KRW 4,550,286,560. The return on equity (ROE) of 7.31% and return on assets (ROA) of 6.58% are in line with industry norms for specialty chemicals, though not significantly outperforming the median. The company's gross margin of 50.1% (calculated from gross profit and revenue) is strong, indicating efficient cost management. LK Chem Co Ltd operates in a single business segment focused on chemical materials for thin film deposition. The company's geographic exposure is concentrated in South Korea, with no disclosed international revenue segments. This concentration may pose risks in the event of regional economic or regulatory changes. The company's revenue growth trajectory is not explicitly provided, but the current price-to-earnings (P/E) ratio of 46.08 and price-to-book (P/B) ratio of 3.37 suggest a premium valuation relative to book value and earnings. The EV/EBITDA of 41.32 and EV/Revenue of 9.32 indicate that the market is pricing in future growth expectations. LK Chem Co Ltd's risk assessment indicates low liquidity and dilution risks. The company has no immediate filing-based liquidity or dilution flags, and the dilution potential is low, with no significant changes in shares outstanding between basic and diluted shares. The company's capital expenditure of KRW -9,995,289,110 (negative due to presentation) suggests a high level of investment in maintaining and expanding production capabilities. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's free cash flow of KRW -3,832,535,040 suggests that capital expenditures are currently outpacing operating cash flow, which may require continued reliance on cash reserves or financing.
Key takeaways
  • LK Chem Co Ltd has a strong liquidity position with a current ratio of 11.94 and significant cash reserves.
  • The company's profitability metrics, including ROE of 7.31% and ROA of 6.58%, are in line with industry norms.
  • The company's valuation multiples (P/E of 46.08, P/B of 3.37) suggest a premium valuation, reflecting market expectations of future growth.
  • LK Chem Co Ltd's operations are concentrated in a single business segment and geographic region, which may increase exposure to regional risks.
  • The company's capital expenditures are high, indicating ongoing investment in production capabilities.
  • The company's risk profile is low, with no immediate liquidity or dilution concerns.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$20.18B
Gross profit$10.11B
Operating income$4.55B
Net income$4.35B
R&D
SG&A
D&A
SBC
Operating cash flow$4.61B
CapEx-$10.00B
Free cash flow-$3.83B
Total assets$66.12B
Total liabilities$6.54B
Total equity$59.59B
Cash & equivalents$16.22B
Long-term debt$3.67B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$20.18B$4.55B$4.35B-$3.83B
FY-1$25.04B$10.14B$6.85B$836.1M
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$66.12B$59.59B$16.22B
FY-1$41.24B$34.41B$9.56B
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0$4.61B-$10.00B-$3.83B
FY-1$10.27B-$6.97B$836.1M
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$5.49B$789.1M$1.30B-$235.5M
FQ-1$5.56B$1.54B$1.57B$461.7M
FQ-2$5.76B$1.75B$1.04B-$2.20B
FQ-3$3.37B$479.7M$443.5M-$1.86B
FQ-4$5.21B$1.27B$1.95B-$2.16B
FQ-5$5.39B$1.89B$123.1M-$1.01B
FQ-6$9.10B$4.92B$3.04B$2.52B
FQ-7$5.34B$2.05B$1.74B$1.48B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$66.12B$59.59B$16.22B
FQ-1$64.83B$58.21B$20.86B
FQ-2$61.87B$56.56B$17.81B
FQ-3$62.43B$55.45B$24.50B
FQ-4$41.24B$34.41B$9.56B
FQ-5$41.78B$32.39B$13.20B
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0$4.61B-$10.00B-$235.5M
FQ-1$2.20B-$7.80B$461.7M
FQ-2$130.2M-$6.18B-$2.20B
FQ-3-$1.83B-$2.62B-$1.86B
FQ-4$10.27B-$6.97B-$2.16B
FQ-5$8.94B-$2.78B-$1.01B
FQ-6$6.65B-$1.36B$2.52B
FQ-7$1.29B-$507.7M$1.48B
Valuation
Market price$31950.00
Market cap$200.58B
Enterprise value$188.03B
P/E46.1
Reported non-GAAP P/E
EV/Revenue9.3
EV/Op income41.3
EV/OCF40.8
P/B3.4
P/Tangible book3.4
Tangible book$59.59B
Net cash$12.55B
Current ratio11.9
Debt/Equity0.1
ROA6.6%
ROE7.3%
Cash conversion1.1%
CapEx/Revenue-49.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric489500Activity
Op margin22.5%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin21.6%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin50.1%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-49.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity6.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 01:01 UTC#9de74239
Market quoteclose KRW 31950.00 · shares 0.01B diluted
no public URL
2026-05-11 01:01 UTC#c221e040
Source: analysis-pipeline (hybrid)Generated: 2026-05-11 01:04 UTCJob: 717e9f8f